ARK Genomic Revolution ETF logo

ARK Genomic Revolution ETF (ARKG)

Market Closed
3 Jun, 20:00
BATS BATS
$
33. 92
-0.08
-0.24%
$
1.21B Market Cap
4.22% Div Yield
2,929,921 Volume
$ 34
Previous Close
Add Transaction
Day Range
32.96 34.01
Year Range
21.34 35.12
Want to track ARKG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
5 Technology ETFs at the Forefront of the August Rebound

5 Technology ETFs at the Forefront of the August Rebound

Wall Street roared back after a sell-off early in the month as fears of recession eased. The technology sector, which bore the biggest brunt, rebounded strongly and once again led the market over the past week.

Zacks | 1 year ago
5 Sector ETFs That Outperformed With Double-Digit Gains in July

5 Sector ETFs That Outperformed With Double-Digit Gains in July

July witnessed the "Great Rotation" in the U.S. stock market as investors shunned the hot technology stocks in favor of smaller companies and other sectors, which are the bigger beneficiaries of the Fed rate cuts.

Zacks | 1 year ago
Best ETFs of Last Week

Best ETFs of Last Week

Wall Street offered a mixed performance last week.

Zacks | 1 year ago
ARKG: A Genomics Play But Active Isn't Adding Value

ARKG: A Genomics Play But Active Isn't Adding Value

Genomics is rapidly advancing, shaping our understanding of health, disease, and life itself. Consider investing in the ARK Genomic Revolution ETF for exposure to leading genomics companies. ARKG's active management may not be outperforming compared to passive genomics ETFs like PBE, with potential regulatory and concentration risks.

Seekingalpha | 1 year ago